Svetlana Nikic, Founder of Precision Oncology Consulting, shared Precision Oncology Consulting’s post on LinkedIn, adding:
“So proud of my team for putting this together – well done Alejandro Aragón Boluda and Carmen Rubio Alarcón.
This is a list of abstracts mentioning CGP (tissue and blood) in the upcoming American Society of Clinical Oncology (ASCO) congress starting in only 2 days.
We will be posting few more of these analysis over coming days so stay tuned and follow me and Precision Oncology Consulting.”
Quoting Precision Oncology Consulting’s post:
“We are excited to share, an overview of abstracts being presented at the upcoming American Society of Clinical Oncology (ASCO) ASCO26, on Comprehensive Genomic Profiling (CGP).
If you are working in the development and implementation of comprehensive genomic profiling (CGP), and do not have yet your ‘must check abstracts’ checklist, make sure to take a look at the overview that we have developed.
We have included all abstracts evaluating CGP (tissue and blood), and have classified them by test developer and type of evidence reported: tes performance, clinical validity, clinical utility and implementation/access.
Regarding test developers: 15 abstracts use the test developed by Foundation Medicine.
- 3 by Illumina,
- 3 by NeoGenomics Laboratories
- 3 by Tempus AI
- 2 by 4baseCare
- 2 by Genekor Medical S.A.
- 2 by Guardant Health
- And 1 by BostonGene, Caris Life Sciences, Datar Cancer Genetics Limited, OneCell.ai diagnostics, OrigiMed Inc. and Precede Biosciences.
Precision Oncology Consulting will be attending ASCO 2026 to stay up to date about the latest advancements in precision oncology and connect with experts in the field.
Learn more about our work: Precision Oncology Consulting
Schedule a meeting via info@precision-oncology-consulting.com or directly via this Calendly link: Meeting Svetlana Nikic at ASCO 2026
Please share/like this post if you find it informative.”
Other articles featuring Svetlana Nikic and Precision Oncology Consulting on OncoDaily.